Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gareth R Evans

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-LetterD Gareth R Evans, Elaine Harkness, Fiona Lalloo
European Journal of Human Genetics : EJHG|November 29, 2012
Can manipulation of splicing offer gene therapy possibilities to those with tumour-prone disorders?D Gareth R Evans, Andrew Wallace, William Newman
Handbook of Clinical Neurology|August 13, 2013
Neurofibromatosis type 2 (NF2): diagnosis and managementSimon K W Lloyd, D Gareth R Evans
European Journal of Human Genetics : EJHG|August 17, 2023
Metaplastic breast cancer and BRCA1: first strong evidence of a linkD Gareth R Evans, Anthony Howell, J Howell Sacha
Clinical Sarcoma Research|October 6, 2012
Malignant peripheral nerve sheath tumours in inherited diseaseD Gareth R Evans, Susan M Huson, Jillian M Birch
Current Opinion in Neurology|January 25, 2003
Neurofibromatosis 2Michael E Baser, D Gareth R Evans, David H Gutmann
JAMA Oncology|March 28, 2020
Future Research Suggestions for Multigene Testing in Unselected Populations-ReplyRanjit Manchanda, Diana S M Buist, D Gareth R Evans
Neurology|March 15, 2006
Increasing the specificity of diagnostic criteria for schwannomatosisMichael E Baser, J M Friedman, D Gareth R Evans
Advances in Oto-Rhino-Laryngology|March 2, 2011
Neurofibromatosis type 2Gareth R Evans, Simon K W Lloyd, Richard T Ramsden
Breast Cancer Research : BCR|March 2, 2013
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relativesD Gareth R Evans, Anthony Howell, Sarah L Ingham, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2017
The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-LetterD Gareth R Evans, Elaine Harkness, Fiona Lalloo
European Journal of Human Genetics : EJHG|November 29, 2012
Can manipulation of splicing offer gene therapy possibilities to those with tumour-prone disorders?D Gareth R Evans, Andrew Wallace, William Newman
Handbook of Clinical Neurology|August 13, 2013
Neurofibromatosis type 2 (NF2): diagnosis and managementSimon K W Lloyd, D Gareth R Evans
European Journal of Human Genetics : EJHG|August 17, 2023
Metaplastic breast cancer and BRCA1: first strong evidence of a linkD Gareth R Evans, Anthony Howell, J Howell Sacha
Clinical Sarcoma Research|October 6, 2012
Malignant peripheral nerve sheath tumours in inherited diseaseD Gareth R Evans, Susan M Huson, Jillian M Birch
Current Opinion in Neurology|January 25, 2003
Neurofibromatosis 2Michael E Baser, D Gareth R Evans, David H Gutmann
JAMA Oncology|March 28, 2020
Future Research Suggestions for Multigene Testing in Unselected Populations-ReplyRanjit Manchanda, Diana S M Buist, D Gareth R Evans
Neurology|March 15, 2006
Increasing the specificity of diagnostic criteria for schwannomatosisMichael E Baser, J M Friedman, D Gareth R Evans
Advances in Oto-Rhino-Laryngology|March 2, 2011
Neurofibromatosis type 2Gareth R Evans, Simon K W Lloyd, Richard T Ramsden
Breast Cancer Research : BCR|March 2, 2013
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relativesD Gareth R Evans, Anthony Howell, Sarah L Ingham, et al.
Pageof 12